Leu-enkephalin Activators
Leu-enkephalin activators, as defined in this context, are a diverse group of chemicals that indirectly influence the activity, release, or synthesis of Leu-enkephalin, one of the key endogenous opioids in the human body. These compounds interact with various receptors and signaling pathways, exerting effects that can lead to increased Leu-enkephalin activity or availability.
Compounds such as capsaicin and resiniferatoxin activate TRPV1 receptors, which can trigger a cascade leading to the release of endogenous opioids, including Leu-enkephalin, as part of the body's natural pain modulation mechanism. This illustrates how external stimuli can indirectly augment the presence of endogenous peptides like Leu-enkephalin. Similarly, agents such as cisplatin and doxorubicin are known to elevate endogenous opioid levels as a physiological response to pain and stress, which can include the upregulation of Leu-enkephalin. Furthermore, compounds acting on central nervous system receptors, such as clonidine, amitriptyline, and the NMDA receptor antagonists ketamine and dextromethorphan, also play a significant role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates TRPV1 receptors, which can lead to an increased release of endogenous opioids including Leu-enkephalin in response to pain signals. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A chemotherapy agent known to increase levels of endogenous opioids for pain modulation. It might stimulate the synthesis or release of Leu-enkephalin as part of this opioid response. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Similar to cisplatin and can potentially increase endogenous opioid levels, including Leu-enkephalin, as a counteraction to pain and stress. | ||||||
Clonidine | 4205-90-7 | sc-501519 | 100 mg | $240.00 | 1 | |
An alpha-2 adrenergic agonist known to enhance the analgesic effects of opioids and might affect the release or activity of endogenous opioids like Leu-enkephalin. | ||||||
Amitriptyline Hydrochloride | 549-18-8 | sc-210801 | 1 g | $200.00 | ||
A tricyclic antidepressant that has been shown to increase endogenous opioid activity, which could include effects on Leu-enkephalin. | ||||||
Dextromethorphan | 125-71-3 | sc-278927 sc-278927A sc-278927B | 10 g 100 g 500 g | $177.00 $1156.00 $5208.00 | 3 | |
Another NMDA receptor antagonist, which could potentially increase the synthesis or release of endogenous opioids including Leu-enkephalin. | ||||||
(±)-Baclofen | 1134-47-0 | sc-200464 sc-200464A | 1 g 5 g | $56.00 $258.00 | ||
A GABA_B receptor agonist that may have indirect effects on opioid receptor signaling, possibly influencing Leu-enkephalin activity. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Primarily used for neuropathic pain, may interact with opioid pathways and could influence the release or activity of Leu-enkephalin. | ||||||